• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泛癌症分析确定 SOAT1 为免疫和预后生物标志物。

A pan-cancer analysis identifies SOAT1 as an immunological and prognostic biomarker.

机构信息

Department of Hepatobiliary Medicine, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.

Department of Hepatobiliary Surgery, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.

出版信息

Oncol Res. 2023 Apr 10;31(2):193-205. doi: 10.32604/or.2023.027112. eCollection 2023.

DOI:10.32604/or.2023.027112
PMID:37304239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10207962/
Abstract

Sterol o-acyltransferase1 (SOAT1) is an enzyme that regulates lipid metabolism. Nevertheless, the predictive value of SOAT1 regarding immune responses in cancer is not fully understood. Herein, we aimed to expound the predictive value and the potential biological functions of SOAT1 in pan-cancer. Raw data related to SOAT1 expression in 33 different types of cancer were acquired from The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) databases. SOAT1 expression was significantly increased in most cancers and showed a distinct correlation with prognosis. This enhanced expression of the SOAT1 gene was confirmed by evaluating SOAT1 protein expression using tissue microarrays. In addition, we found significant positive associations between SOAT1 expression levels and infiltrating immune cells, including T cells, neutrophils, and macrophages. Moreover, the co-expression analysis between SOAT1 and immune genes showed that many immune-related genes were increased with enhanced SOAT1 expression. A gene set enrichment analysis (GSEA) revealed that the expression of SOAT1 correlated with the tumor microenvironment, adaptive immune response, interferon signaling, and cytokine signaling. These findings indicate that SOAT1 is a potential candidate marker for predicting prognosis and a promising target for tumor immunotherapy in cancers.

摘要

甾醇 O-酰基转移酶 1(SOAT1)是一种调节脂质代谢的酶。然而,SOAT1 对癌症中免疫反应的预测价值尚未完全阐明。在此,我们旨在阐述 SOAT1 在泛癌中的预测价值和潜在生物学功能。从癌症基因组图谱(TCGA)和基因型组织表达(GTEx)数据库中获取了 33 种不同类型癌症中与 SOAT1 表达相关的原始数据。SOAT1 在大多数癌症中的表达显著增加,并与预后有明显相关性。通过使用组织微阵列评估 SOAT1 蛋白表达,证实了 SOAT1 基因的这种增强表达。此外,我们发现 SOAT1 表达水平与浸润性免疫细胞(包括 T 细胞、中性粒细胞和巨噬细胞)之间存在显著的正相关关系。此外,SOAT1 与免疫基因的共表达分析表明,许多与免疫相关的基因随着 SOAT1 表达的增强而增加。基因集富集分析(GSEA)显示,SOAT1 的表达与肿瘤微环境、适应性免疫反应、干扰素信号和细胞因子信号相关。这些发现表明,SOAT1 是预测预后的潜在候选标志物,也是癌症肿瘤免疫治疗的有前途的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c375/10207962/f5a3e2fe4a3d/OncolRes-31-27112-s003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c375/10207962/4709ee488774/OncolRes-31-27112-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c375/10207962/8a5308f40650/OncolRes-31-27112-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c375/10207962/a0f10591a393/OncolRes-31-27112-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c375/10207962/a96ea7fd7aed/OncolRes-31-27112-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c375/10207962/901faa3e3a56/OncolRes-31-27112-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c375/10207962/baef427bfa77/OncolRes-31-27112-f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c375/10207962/3aa6f19b82ac/OncolRes-31-27112-s001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c375/10207962/650e7607ac94/OncolRes-31-27112-s002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c375/10207962/f5a3e2fe4a3d/OncolRes-31-27112-s003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c375/10207962/4709ee488774/OncolRes-31-27112-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c375/10207962/8a5308f40650/OncolRes-31-27112-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c375/10207962/a0f10591a393/OncolRes-31-27112-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c375/10207962/a96ea7fd7aed/OncolRes-31-27112-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c375/10207962/901faa3e3a56/OncolRes-31-27112-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c375/10207962/baef427bfa77/OncolRes-31-27112-f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c375/10207962/3aa6f19b82ac/OncolRes-31-27112-s001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c375/10207962/650e7607ac94/OncolRes-31-27112-s002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c375/10207962/f5a3e2fe4a3d/OncolRes-31-27112-s003.jpg

相似文献

1
A pan-cancer analysis identifies SOAT1 as an immunological and prognostic biomarker.泛癌症分析确定 SOAT1 为免疫和预后生物标志物。
Oncol Res. 2023 Apr 10;31(2):193-205. doi: 10.32604/or.2023.027112. eCollection 2023.
2
Comprehensive Analysis of as a Prognostic Biomarker and Its Association With Immune Infiltration in Glioma.作为胶质瘤预后生物标志物的综合分析及其与免疫浸润的关联
Front Oncol. 2022 May 12;12:896433. doi: 10.3389/fonc.2022.896433. eCollection 2022.
3
Comprehensive prognostic and immune analysis of sterol O-acyltransferase 1 in patients with hepatocellular carcinoma.肝细胞癌患者中固醇O-酰基转移酶1的综合预后及免疫分析
World J Hepatol. 2024 Mar 27;16(3):439-451. doi: 10.4254/wjh.v16.i3.439.
4
Systematic pan-cancer analysis identifies cuproptosis-related gene DLAT as an immunological and prognostic biomarker.系统性泛癌症分析确定 cuproptosis 相关基因 DLAT 为免疫和预后生物标志物。
Aging (Albany NY). 2023 May 17;15(10):4269-4287. doi: 10.18632/aging.204728.
5
Sperm Autoantigenic Protein 17 Predicts the Prognosis and the Immunotherapy Response of Cancers: A Pan-Cancer Analysis.精子自身抗原蛋白 17 预测癌症的预后和免疫治疗反应:泛癌分析。
Front Immunol. 2022 May 3;13:844736. doi: 10.3389/fimmu.2022.844736. eCollection 2022.
6
CDK16 as a potential prognostic biomarker correlated with an immunosuppressive tumor microenvironment and benefits in enhancing the effectiveness of immunotherapy in human cancers.细胞周期蛋白依赖性激酶16(CDK16)作为一种潜在的预后生物标志物,与免疫抑制性肿瘤微环境相关,且有助于提高人类癌症免疫治疗的效果。
Aging (Albany NY). 2024 Jan 22;16(2):1879-1896. doi: 10.18632/aging.205465.
7
SHCBP1 Is a Prognostic Biomarker Related to the Tumour Immune Microenvironment in Pan-Cancer.SHCBP1是一种与泛癌肿瘤免疫微环境相关的预后生物标志物。
Ann Clin Lab Sci. 2022 Nov;52(6):904-917.
8
Protein Disulfide-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response Effectively.蛋白二硫键异构酶 A3 是癌症强有力的预后生物标志物,并能有效预测免疫治疗反应效果。
Front Immunol. 2022 Mar 25;13:837512. doi: 10.3389/fimmu.2022.837512. eCollection 2022.
9
LncRNA WAC-AS1 expression in human tumors correlates with immune infiltration and affects prognosis.LncRNA WAC-AS1 在人类肿瘤中的表达与免疫浸润相关,并影响预后。
Hereditas. 2023 May 30;160(1):26. doi: 10.1186/s41065-023-00290-z.
10
POC1A, prognostic biomarker of immunosuppressive microenvironment in cancer.POC1A,癌症免疫抑制微环境的预后生物标志物。
Aging (Albany NY). 2022 Jun 23;14(12):5195-5210. doi: 10.18632/aging.204141.

引用本文的文献

1
Integrative eQTL and Mendelian randomization analysis reveals key genetic markers in mesothelioma.整合性表达数量性状基因座(eQTL)与孟德尔随机化分析揭示了间皮瘤中的关键遗传标记。
Respir Res. 2025 Apr 13;26(1):140. doi: 10.1186/s12931-025-03219-4.
2
Relative expression orderings based prediction of treatment response to Anti-PD-1 immunotherapy in advanced melanoma.基于相对表达排序预测晚期黑色素瘤抗程序性死亡蛋白1免疫治疗的反应
Sci Rep. 2025 Mar 25;15(1):10235. doi: 10.1038/s41598-025-94931-0.
3
Exploring the biological behavior differences between retroperitoneal and non-retroperitoneal liposarcomas.

本文引用的文献

1
Comprehensive Analysis of as a Prognostic Biomarker and Its Association With Immune Infiltration in Glioma.作为胶质瘤预后生物标志物的综合分析及其与免疫浸润的关联
Front Oncol. 2022 May 12;12:896433. doi: 10.3389/fonc.2022.896433. eCollection 2022.
2
SOAT1 Promotes Gastric Cancer Lymph Node Metastasis Through Lipid Synthesis.SOAT1通过脂质合成促进胃癌淋巴结转移。
Front Pharmacol. 2021 Nov 1;12:769647. doi: 10.3389/fphar.2021.769647. eCollection 2021.
3
SOAT1 enhances lung cancer invasiveness by stimulating AKT-mediated mitochondrial fragmentation.
探索腹膜后脂肪肉瘤与非腹膜后脂肪肉瘤之间的生物学行为差异。
Heliyon. 2024 Jul 19;10(15):e34878. doi: 10.1016/j.heliyon.2024.e34878. eCollection 2024 Aug 15.
SOAT1通过刺激AKT介导的线粒体分裂来增强肺癌的侵袭性。
Biochem Cell Biol. 2022 Feb;100(1):68-74. doi: 10.1139/bcb-2021-0175. Epub 2021 Oct 20.
4
High expression of Sterol-O-Acyl transferase 1 (SOAT1), an enzyme involved in cholesterol metabolism, is associated with earlier biochemical recurrence in high risk prostate cancer.固醇-O-酰基转移酶 1(SOAT1)表达水平升高与胆固醇代谢有关,与高危前列腺癌的早期生化复发相关。
Prostate Cancer Prostatic Dis. 2022 Sep;25(3):484-490. doi: 10.1038/s41391-021-00431-3. Epub 2021 Jul 29.
5
Stratification of patients with clear cell renal cell carcinoma to facilitate drug repositioning.对肾透明细胞癌患者进行分层以促进药物重新定位。
iScience. 2021 Jun 12;24(7):102722. doi: 10.1016/j.isci.2021.102722. eCollection 2021 Jul 23.
6
Targeting human Acyl-CoA:cholesterol acyltransferase as a dual viral and T cell metabolic checkpoint.靶向人酰基辅酶 A:胆固醇酰基转移酶作为双重病毒和 T 细胞代谢检查点。
Nat Commun. 2021 May 14;12(1):2814. doi: 10.1038/s41467-021-22967-7.
7
Cholesterol activates the Wnt/PCP-YAP signaling in SOAT1-targeted treatment of colon cancer.胆固醇在SOAT1靶向治疗结肠癌中激活Wnt/PCP-YAP信号通路。
Cell Death Discov. 2021 Feb 26;7(1):38. doi: 10.1038/s41420-021-00421-3.
8
Knockdown of sterol O-acyltransferase 1 (SOAT1) suppresses SCD1-mediated lipogenesis and cancer procession in prostate cancer.固醇 O-酰基转移酶 1(SOAT1)的敲低抑制 SCD1 介导的前列腺癌细胞脂肪生成和癌变过程。
Prostaglandins Other Lipid Mediat. 2021 Apr;153:106537. doi: 10.1016/j.prostaglandins.2021.106537. Epub 2021 Jan 14.
9
Cholesterol metabolism: New functions and therapeutic approaches in cancer.胆固醇代谢:癌症的新功能和治疗方法。
Biochim Biophys Acta Rev Cancer. 2020 Aug;1874(1):188394. doi: 10.1016/j.bbcan.2020.188394. Epub 2020 Jul 19.
10
SOAT1 promotes mevalonate pathway dependency in pancreatic cancer.SOAT1 促进胰腺癌中甲羟戊酸途径的依赖性。
J Exp Med. 2020 Sep 7;217(9). doi: 10.1084/jem.20192389.